Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT06307938

Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer

Led by Helse Nord-Trøndelag HF · Updated on 2025-04-30

3000

Participants Needed

1

Research Sites

164 weeks

Total Duration

On this page

Sponsors

H

Helse Nord-Trøndelag HF

Lead Sponsor

N

Norwegian University of Science and Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

CoLiQ is a clinical study designed to evaluate the clinical usefulness of circulating tumor DNA (ctDNA) markers found in blood, as a liquid biopsy for diagnosis, prognosis and follow-up of colorectal cancer. The main questions it aims to answer are: 1) Can a panel of ctDNA markers identify CRC patients among the other patients summoned for colonoscopy? and 2) Does the type, number and level of ctDNA markers vary with the subtype and clinical course of CRC? Participants will be asked to answer a questionnaire and give a blood sample at inclusion. In addition, patients with CRC will be asked to give an extra test tube at their routine treatment and follow-up blood sampling.

CONDITIONS

Official Title

Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient 63 18 years old summoned for colonoscopy
  • Patient able to understand and sign written informed consent
Not Eligible

You will not qualify if you...

  • Patient < 18 years old
  • Patient unable to understand or give written informed consent
  • Patient unlikely to comply with the protocol (e.g. uncooperative attitude, inability to return for subsequent visits) and/or otherwise considered by the investigator as unlikely to complete the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Nord-Trøndelag Hospital Trust

Levanger, Norway, N-7600

Actively Recruiting

Loading map...

Research Team

E

Eivor A Laugsand, MD, PhD

CONTACT

S

Siv S Brenne, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here